Changes in the Prescription of Glucose-Lowering Medications in Patients With Type 2 Diabetes Mellitus After a Cardiovascular Event: A Call to Action From the DATAFILE Study.
第一作者:
Gian Paolo,Fadini
第一单位:
1 Department of Medicine University of Padova Italy.
作者:
主题词
肾上腺素能β受体拮抗剂(Adrenergic beta-Antagonists);老年人(Aged);血管紧张素受体拮抗剂(Angiotensin Receptor Antagonists);血管紧张素转换酶抑制药(Angiotensin-Converting Enzyme Inhibitors);心血管疾病(Cardiovascular Diseases);胆固醇, LDL(Cholesterol, LDL);糖尿病, 2型(Diabetes Mellitus, Type 2);女(雌)性(Female);心力衰竭(Heart Failure);人类(Humans);羟甲基戊二酰基CoA还原酶抑制剂(Hydroxymethylglutaryl-CoA Reductase Inhibitors);降血糖药(Hypoglycemic Agents);意大利(Italy);男(雄)性(Male);二甲双胍(Metformin);中年人(Middle Aged);心肌梗死(Myocardial Infarction);心肌缺血(Myocardial Ischemia);心肌血管重建术(Myocardial Revascularization);钠钾氯同向转运体抑制剂(Sodium Potassium Chloride Symporter Inhibitors)
DOI
10.1161/JAHA.119.012244
PMID
31269877
发布时间
2022-12-07
- 浏览1
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文